Claudio D'Angelo
Angel Investor @ RYSE Asset Management
London, United Kingdom
Claudio D'Angelo is a non-equity assistance investor at RYSE Asset Management in London focused on Apps and SaaS. Claudio D'Angelo is based out of London, England and is the Founder and CEO of Spex Capital. Claudio D'Angelo previously worked at J Invest as a Chairman Of The Board Of Directors. Claudio D'Angelo attended the Alma Mater Studiorum – Università di Bologna.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Claudio D'Angelo invests in
Stages Claudio D'Angelo invests in
Countries Claudio D'Angelo invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Apps 1 (100%)
- SaaS 1 (100%)
- Hospital 1 (100%)
- Software 1 (100%)
- Health Care 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MediShout is a digital platform to improve operational efficiencies, so healthcare staff can focus on patient care. MediShout brings calmness to chaotic wards and turns hospitals into smart and automated buildings. Our technology connects staff, systems, machines, and work-flow; thus improving efficiency and care. Our cloud-based technologyconnects people, Helpdesks, smartphones, tablets, IT systems, and RFID tagging. | Non-equity Assistance / Jul 02, 2020 |
About RYSE Asset Management
Our focus is to help healthcare founders go further. Since 2015, RYSE has been supporting technology companies to achieve accelerated global growth and scale by connecting high-potential healthcare founders with established distribution partners.In 2018/20, RYSE DigitalHealth.London investment programmes translated great ideas intoreal-world solutions by partnering with healthcare founders with clinical experience who know how to serve patients best.Our dream is to be globally admired as the most transformative partner for healthcare innovators.
RYSE Asset Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Shabir Chowdhary
Managing Partner
|
|||
Vivien de Tusch-Lec
General Partner
|
|||
Chris Turner
Entrepreneur-in-Residence
|
|||
Dr Carina Tyrrell
Entrepreneur-in-Residence
|
|||
Dr John Lee Allen
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Claudio D'Angelo invest in?
Claudio D'Angelo invests primarily in Apps, SaaS and Hospital startups, most often at Non-equity Assistance stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Claudio D'Angelo?
Public channels for Claudio D'Angelo include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Claudio D'Angelo last invest?
The most recent investment recorded for Claudio D'Angelo closed in Jul 2020. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
